1. - Clinica malattie apparato respiratorio

4. MANAGEMENT CLINICO DELLA BPCO
11. Burge PS et al: Randomised, double blind, placebo
controlled study of fluticasone propionate in patients
with moderate to severe chronic obstructive
pulmonary disease: the ISOLDE trial. BMJ 2000;
320(7245):1297-1303.
12. Niewoehner DE et al: Effect of systemic glucocorticoids
on exacerbations of chronic obstructive pulmonary
disease. Department of Veterans Affairs
Cooperative Study Group. N Engl J Med 1999;
340(25):1941-1947.
13. Pauwels RA et al: Long-term treatment with inhaled
budesonide in persons with mild chronic obstructive
pulmonary disease who continue smoking.
European Respiratory Society Study on Chronic
Obstructive Pulmonary Disease. N Engl J Med
1999; 340(25):1948-1953.
14. Buist AS: Similarities and differences between asthma
and chronic obstructive pulmonary disease:
treatment and early outcomes. Eur Respir J 2003;
(Suppl )39:30s-35s.
15. Pope CA 3rd et al: Lung cancer, cardiopulmonary
mortality, and long-term exposure to fine particulate
air pollution. Jama 2002; 287(9):1132-1141.
16. Fabbri LM et al: Differences in airway inflammation
in patients with fixed airflow obstruction due to
asthma or chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 2003; 167(3):418-424.
17. Van Schayck CP et al: Detecting patients at a high
risk of developing chronic obstructive pulmonary
disease in general practice: cross sectional case finding
study. BMJ 2002; 324(7350):1370.
18. Celli BR:The importance of spirometry in COPD
and asthma: effect on approach to management.
Chest 2000; 117(2 Suppl):15S-19S.
19. Vestbo J e Lange P: Can GOLD Stage 0 provide
information of prognostic value in chronic obstructive
pulmonary disease Am J Respir Crit Care
Med 2002; 166(3):329-332.
20. Cerveri I et al: Gold stage 0.Am J Respir Crit Care
Med 2003; 167(6):936.
21. Doherty DE: Early detection and management of
COPD. What you can do to reduce the impact of
this disabling disease. Postgrad Med 2002; 111(6):
41-44, 49-50, 53 passim.
22. Pauwels RA et al: Global strategy for the diagnosis,
management, and prevention of chronic obstructive
pulmonary disease: National Heart, Lung,
and Blood Institute and World Health Organization
Global Initiative for Chronic Obstructive Lung Disease
(GOLD): executive summary. Respir Care
2001; 46(8):798-825.
23. Yohannes AM e Hardy CC: Treatment of chronic
obstructive pulmonary disease in older patients: a
practical guide. Drugs Aging 2003; 20(3):209-228.
24. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J:Are
guidelines following guidelines The methodological
quality of clinical practice guidelines in the
peer-reviewed medical literature. Jama 1999;
281(20): 1900-1905.
25. Cartabellotta A, Montalto G, Notarbartolo A: [Levels
of scientific evidence and strength of clinical recommendations.
From trials to guidelines. The Italian
Group on Medicine Based on Evidence—(GIM-
BE)]. Recenti Prog Med 1997; 88(7-8):342-347.
26. Woolf SH et al: Clinical guidelines: potential benefits,
limitations, and harms of clinical guidelines.
BMJ 1999; 318(7182):527-530.
27. Ferguson GT: Recommendations for the management
of COPD. Chest 2000; 117(2 Suppl):23S-28S.
28. Smith BJ et al: Systematic assessment of clinical
practice guidelines for the management of chronic
obstructive pulmonary disease. Respir Med 2003;
97(1):37-45.
29. MacNee W e Calverley PM: Chronic obstructive
pulmonary disease * 7: Management of COPD.
Thorax 2003; 58(3):261-265.
30. Celli BR: Standards for the optimal management
of COPD: a summary. Chest 1998; 113(4Suppl):283S-287S.
31. Sturani C e Potena A: L’impatto della broncopneumopatia
cronica ostruttiva: il razionamento dei ricoveri
è un disastro non etico e non evidence-based.
Rass Pat App Resp 2002; 17:171-172.
32. Miravitlles M et al: Pharmacoeconomic evaluation
of acute exacerbations of chronic bronchitis and
COPD. Chest 2002; 121(5):1449-1455.
33. Incalzi RA et al: Exacerbated chronic obstructive
pulmonary disease: a frequently unrecognized condition.
J Intern Med 2002; 252(1):48-55.
34. Putinati S et al: Is it possible to predict the success
of non-invasive positive pressure ventilation in acute
respiratory failure due to COPD Respir Med
2000; 94(10):997-1001.
35. Rampulla C et al: La valutazione delle malattie respiratorie
nella nuova legislazione italiana. Trattato
Italiano di Pneumologia, 2003 Edizioni EDI AIPO
In stampa. 4°.
89